NCT06074068 Father-Focused Intervention for Reducing Family Violence and Symptoms in Children
| NCT ID | NCT06074068 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yale University |
| Condition | Intimate Partner Violence |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,080 participants |
| Start Date | 2024-01-11 |
| Primary Completion | 2028-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,080 participants in total. It began in 2024-01-11 with a primary completion date of 2028-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to test the efficacy of Fathers for Change (F4C) compared to standard Batterer Intervention for fathers with a history of Intimate Partner Violence. The main question\[s\] it aims to answer are: 1. Is F4C more efficacious than standard BIP in reducing family violence and child mental health impairment? 2. What are the trajectories of therapeutic change targets across interventions? 3. Does father's emotion regulation and reflective functioning mediate the relationship between the two interventions and child-related outcomes? Participants will be randomized to either Fathers for Change on Batterer Intervention.
Eligibility Criteria
Inclusion Criteria: * have at least one 6 month to 12-year-old biological child with whom they have contact; * had an incident of IPV within the last 12 months prior to screening with their child's mother (based on court/police records, coparent or self-report); * have a currently open or recently investigated (in the last 6 months) case with CT DCF * are able to complete assessments in English or Spanish; * agree to have their female coparents (mother of target child) contacted as collateral informants and for consent for participation of their child. If a participant has more than one child in the age range, the youngest will be selected; * female coparents (i.e., biological mother who need not be in a relationship with the father) consents to (at minimum) provide parent-report on child; however, may opt out of child participation. If the coparent agrees to participate by providing caregiver-report on child symptoms, but declines participation of their shared child, the father may still participate in the study if he meets eligibility criteria outlined below; thus, preventing any possible retaliation against co-parents for not consenting to child participation. Exclusion Criteria: Fathers will be excluded based on the following exclusion criteria: * an active full/no contact protective order pertaining to their child because this will preclude participation in the father-child play assessment (many men will have protective orders pertaining to their partners, but it is more common for men to still be allowed contact with their children); * physiological addiction to a substance that requires detoxification. Fathers will be evaluated using the Drug Abuse Screening Test and AUDIT. If fathers report significant difficulties with physiological withdrawal (e.g., alcohol tremors or dope sickness) they will be referred for detox services. They can be re-evaluated following a detox program with documentation from the detox center of successful completion and clean urine screen; * cognitive impairment that will not allow for understanding of the study interventions (a mini mental state score \<25); * current untreated psychotic disorder; * currently suicidal or homicidal ideation based on screening using the BSI; or * previously participated in F4C or a BIP.
Contact & Investigator
Carla S Stover, PhD
PRINCIPAL INVESTIGATOR
Yale University
Frequently Asked Questions
Who can join the NCT06074068 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Intimate Partner Violence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06074068 currently recruiting?
Yes, NCT06074068 is actively recruiting participants. Contact the research team at carla.stover@yale.edu for enrollment information.
Where is the NCT06074068 trial being conducted?
This trial is being conducted at New Haven, United States, West Hartford, United States.
Who is sponsoring the NCT06074068 clinical trial?
NCT06074068 is sponsored by Yale University. The principal investigator is Carla S Stover, PhD at Yale University. The trial plans to enroll 1,080 participants.